THE HUMAN PROTEIN ATLAS BLOG

650 genes associated with prognosis in Lung Cancer

2017-10-13
Cancer CancerProteomics Immunohistochemistry Lung cancer Pathology Atlas Proteomics TCGA

Figure 1. Immunohistochemical staining of MPC1 using antibody HPA045119 shows differential expression pattern, both high (left panel) and low (right panel), in samples from lung cancer patients.

As part of the release Pathology Atlas release, the Human Protein Atlas will each week present a brief and informative summary highlighting genes with prognostic association in different cancer forms. This week, we will focus on Lung cancer one of the deadliest cancers in the world today.

Lung cancer patients have a poor outcome with a 5-year survival rate of 13.6% in men and 19.4% in women. Late diagnosis and lack of effective treatments are considered to contribute to poor prognosis. Smoking is the leading risk factor and is responsible for 70-90% of the lung cancer cases. Lung cancer can be divided into small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC)...Read more


Blog archive

2020
2019
2018
2017 (57)
2016 (76)
2015 (13)